Sales force field teams are slashed 30, 40, or 50 percent while territories mushroom. New competitors emerge, and everyone
is required to do more with less. Physicians limit access, and eventually close their doors—for good. Now, another roadblock
has resurfaced, and it's bigger than ever: compliance.
Compliance used to be an issue that primarily affected Sample Operations, Quality Assurance, and Manufacturing; but now the
concern is enterprise-wide. And it's not a simple case of creating a new SOP. Today, compliance is a moving target; the rules
change as often as the weather.
Handicapped by Sunshine
Consider aggregate state expenditure compliance. Six states and Washington, DC, have enacted legislation mandating life sciences
companies to track and disclose their sales and marketing expenditures on physicians, and at least 20 states have introduced
similar legislation. However, each of these states has different reporting requirements and defines soft-dollar spending in
different ways. Some have already changed these complicated regulations more than once. Soon, the Federal Sunshine Act will
add another layer of complexity to the situation.
Off-label product promotion is another (more costly) example of how unexpected changes in regulatory weather patterns can
affect sales. Who can forget the PhRMA litigations over off-label product promotion in 2009? Certainly not Pfizer, AstraZeneca,
and Eli Lilly, each of which were each slammed with hefty fines. According to the Wall Street Journal, AstraZeneca is set
to pay $520 million on its antipsychotic Seroquel claims, which is just a fraction of the cost of off-label promotion settlements
at Eli Lilly ($1.4 billion) and Pfizer ($2.3 billion).
The effect of these and so many other confusing and constantly changing rules can paralyze sales forces, destroy morale, and
ultimately detract from performance. Understandably, reps become more hesitant, which is a huge handicap in today's fiercely
competitive market. Even the best sales reps, who are typically fast-acting and opportunistic, can become agonizingly cautious
in the face of these obstacles. And when the very traits that once defined a skilled sales person begin to fade, your market
dominance will do the same.
How can companies keep their sales teams strong enough to weather any compliance storm?
Better Training and New Tools
Life sciences sales teams require even more training than in years past. Ten years ago, reps were trained on a small range
of products once or twice a year. Today, they must know how to detail three times as many products, which can change every
quarter. In addition, reps must learn complex selling strategies based on formulary position; how to work with physicians
given their patients' payer mix; aggregate state expenditure compliance rules; off-label product promotion restrictions; and
The good news is that training reps on all this material with a limited budget is simpler than you might think. Just use the
latest technology. New training tools built on flexible architectures like software-as-a-service (SaaS) allow life sciences
companies to train salespeople efficiently via the Web. Cisco's WebEx,for example, offers a SaaS application that delivers
dynamic, interactive training to employees anywhere in the world. Sales managers can share visual content in real time; participants
conference in by phone, so they all see and hear the whole demonstration as it happens. Because it's a SaaS application, there's
no hardware to buy or software to install, and upgrades are included. Its multi-tenant architecture enables unparalleled scalability,
flexibility, and efficiency.
Multi-tenant SaaS applications are built to serve multiple customers from a single, shared application. In the same way a
multi-tenant apartment building provides the advantages of economies of scale (i.e., higher powered HVAC systems, industrial-strength
elevators, grounds staff, etc), so do multi-tenant SaaS applications. Customers don't have to worry about maintaining the
system, they just have to focus on making it fit their requirements, including any specific needs that will help ensure compliance.
With 10 million users globally, including new users at AstraZeneca, Plateau offers a SaaS training system that enhances the
experience for companies of all sizes. This learning management system's SaaS platform enables it to provide customers with
curricula that can be changed as quickly as compliance rules.
In addition to advanced training systems, there are a number of other technology tools, such as closed loop marketing (CLM),
that can help sales reps shoulder the heavy burden of regulatory compliance. Used in conjunction with a SaaS customer relationship
management (CRM) or sales force automation (SFA) system, CLM tools allow companies to control all of the content physicians
see, making compliance much less of a burden on salespeople.
Exploria SPS offers a SaaS CLM system that integrates with CRM systems to allow brand and sales teams to customize messaging
to every physician in every interaction. A business-rule-driven CLM program within a flexible CRM system gives sales teams
the power to create customer details for individual physicians that can be changed as often as necessary to incorporate new
That's powerful stuff—especially when that new information happens to be the FDA's "regulation of the week." In fact, the
Wall Street Journal recently reported that Pfizer is rolling out a SaaS CRM/CLM system that includes parameters designed to
ensure that sales reps are appropriately distributing drug samples, discussing products, and handling physician requests for
medical information. The new system is expected to guide reps when detailing products, so that they know exactly which samples
can be signed for, and what content can be shown to a physician based on his or her specialty and the approved uses of the
company's medicines. Because the new system is built on the popular cloud computing model, all of this information can be
changed as often as needed to reflect changes in compliance regulations.